Table 3 Relationship between PNI and the clinicopathologic features
Variables | PNI < 45 (n = 97) | PNI ≥ 45 (n = 85) | p value | |
|---|---|---|---|---|
Age | < 70 | 13 (13.4%) | 77 (90.6%) | < 0.001 |
≥ 70 | 84 (86.6%) | 8 (9.4%) | ||
Sex | Male | 70 (72.2%) | 60 (70.6%) | 0.814 |
Female | 27 (27.8%) | 25 (29.4%) | ||
BMI | < 25 | 74 (76.3%) | 59 (69.4%) | 0.298 |
≥ 25 | 23 (23.7%) | 26 (30.6%) | ||
Comorbidities | ||||
Myocardial infarction | present | 7 (7.2%) | 0 (0.0%) | 0.999 |
absent | 90 (92.8%) | 85 (100.0%) | ||
Congestive heart failure | present | 10 (10.3%) | 1 (1.2%) | 0.032 |
absent | 87 (89.7%) | 84 (98.8%) | ||
Cerebrovascular accident | present | 9 (9.3%) | 3 (3.5%) | 0.133 |
absent | 88 (90.7%) | 82 (96.5%) | ||
COPD | present | 12 (12.4%) | 2 (2.4%) | 0.023 |
absent | 85 (87.6%) | 83 (97.6%) | ||
Liver disease | present | 6 (6.2%) | 0 (0.0%) | 0.999 |
absent | 91 (93.8%) | 85 (100.0%) | ||
Chronic kidney disease | present | 2 (2.1%) | 0 (0.0%) | 0.999 |
absent | 95 (97.9%) | 85 (100.0%) | ||
Diabetes mellitus | present | 18 (18.6%) | 17 (20.0%) | 0.805 |
absent | 79 (81.4%) | 68 (80.0%) | ||
Stage | I | 50 (51.5%) | 64 (75.3%) | 0.008 |
II | 28 (28.9%) | 10 (11.8%) | ||
III | 19 (19.6%) | 11 (12.9%) | ||
Tumor size | 50 > | 55 (56.7%) | 68 (80.0%) | 0.001 |
≥ 50 | 42 (43.3%) | 17 (20.0%) | ||
Lymphatic vessel infiltration | present | 52 (53.6%) | 28 (32.9%) | 0.005 |
absent | 45 (46.4%) | 57 (67.1%) | ||
Histologic type | Intestinal | 59 (60.8%) | 43 (50.6%) | 0.166 |
Diffuse | 38 (39.2%) | 42 (49.4%) | ||
Operative method | Distal | 68 (70.1%) | 56 (65.9%) | 0.330 |
Total | 27 (27.8%) | 24 (28.2%) | ||
Proximal | 2 (2.1%) | 5 (5.9%) | ||
Lymph node dissection | D1 | 4 (4.1%) | 28 (32.9%) | 0.001 |
D1+ | 48 (49.5%) | 26 (30.6%) | ||
D2 | 45 (46.4%) | 31 (36.5%) | ||
Complication (CD ≥ 3) | present | 6 (6.2%) | 3 (3.5%) | 0.415 |
absent | 91 (93.8%) | 82 (96.5%) | ||
Complication (infection) | present | 11 (11.3%) | 3 (3.5%) | 0.062 |
absent | 86 (88.7%) | 82 (96.5%) | ||